Man Group
BIVI icon

Man Group’s BioVie BIVI Stock Holding History

Man Group’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-183
Closed -$121K – 1950
2022
Q4 		$143K Buy
+183
New +$98.9K ﹤0.01% 1838

Other funds holding BIVI

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Man Group's BIVI Position: Q1 2023 in Review

Man Group sold out of BioVie (BIVI) in Q1 2023, closing a stake of 183 shares — an estimated $121K sold.

Man Group first reported a position in BIVI in Q4 2022 and held it in 1 quarter. The position peaked at $143K in Q4 2022. 47 funds tracked by Wall St. Rank hold BIVI as of Q1 2023.

  • Man Group reported no remaining BioVie position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 183 BioVie shares in Q1 2023, an estimated $121K.
  • Man Group first reported a position in BioVie in Q4 2022 and held it in 1 quarter.
  • Man Group's BioVie position peaked at $143K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held BioVie as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.